Cargando…

Avian influenza

The current epidemic of H5N1 highly pathogenic avian Influenza in Southeast Asia raises serious concerns that genetic reassortment will result in the next Influenza pandemic. There have been 164 confirmed cases of human infection with avian Influenza since 1996. In 2004 alone, there were 45 cases of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeitlin, Gary A., Maslow, Melanie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Current Medicine Group 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089356/
https://www.ncbi.nlm.nih.gov/pubmed/16566867
http://dx.doi.org/10.1007/s11882-006-0055-y
_version_ 1783509719019683840
author Zeitlin, Gary A.
Maslow, Melanie J.
author_facet Zeitlin, Gary A.
Maslow, Melanie J.
author_sort Zeitlin, Gary A.
collection PubMed
description The current epidemic of H5N1 highly pathogenic avian Influenza in Southeast Asia raises serious concerns that genetic reassortment will result in the next Influenza pandemic. There have been 164 confirmed cases of human infection with avian Influenza since 1996. In 2004 alone, there were 45 cases of human H5N1 in Vietnam and Thailand, with a mortality rate over 70%. In addition to the potential public health hazard, the current zoonotic epidemic has caused severe economic losses. Efforts must be concentrated on early detection of bird outbreaks with aggressive culling, quarantines, and disinfection. To prepare for and prevent increased human cases, it is essential to improve detection methods and stockpile effective antivirals. Novel therapeutic modalities, including short, interfering RNAs and new vaccine strategies that use plasmid-based genetic systems offer promise, should a pandemic occur.
format Online
Article
Text
id pubmed-7089356
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Current Medicine Group
record_format MEDLINE/PubMed
spelling pubmed-70893562020-03-23 Avian influenza Zeitlin, Gary A. Maslow, Melanie J. Curr Allergy Asthma Rep Article The current epidemic of H5N1 highly pathogenic avian Influenza in Southeast Asia raises serious concerns that genetic reassortment will result in the next Influenza pandemic. There have been 164 confirmed cases of human infection with avian Influenza since 1996. In 2004 alone, there were 45 cases of human H5N1 in Vietnam and Thailand, with a mortality rate over 70%. In addition to the potential public health hazard, the current zoonotic epidemic has caused severe economic losses. Efforts must be concentrated on early detection of bird outbreaks with aggressive culling, quarantines, and disinfection. To prepare for and prevent increased human cases, it is essential to improve detection methods and stockpile effective antivirals. Novel therapeutic modalities, including short, interfering RNAs and new vaccine strategies that use plasmid-based genetic systems offer promise, should a pandemic occur. Current Medicine Group 2006 /pmc/articles/PMC7089356/ /pubmed/16566867 http://dx.doi.org/10.1007/s11882-006-0055-y Text en © Current Science Inc 2006 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Zeitlin, Gary A.
Maslow, Melanie J.
Avian influenza
title Avian influenza
title_full Avian influenza
title_fullStr Avian influenza
title_full_unstemmed Avian influenza
title_short Avian influenza
title_sort avian influenza
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089356/
https://www.ncbi.nlm.nih.gov/pubmed/16566867
http://dx.doi.org/10.1007/s11882-006-0055-y
work_keys_str_mv AT zeitlingarya avianinfluenza
AT maslowmelaniej avianinfluenza